Clinical Trials Insight: 700033689
Phase of Trial: Phase I
Latest Information Update: 19 May 2008
At a glance
- Drugs Adipiplon (Primary)
- Indications Anxiety disorders
- Focus Pharmacodynamics
- Sponsors Neurogen Corporation
- 19 May 2008 New trial record.
- 08 May 2008 Results are expected by the end of 2008, according to information from a Neurogen Corporation media release.